Brexit denies UK children access to life-extending drug for aggressive brain cancer

Exclusive: Experts say Brexit has led to delays in the launch of clinical trials and increased costs for multiple drugs. They are urging the government to reset the UK’s relationship with Europe to reopen access to potentially life-changing treatments

Raccontata daindependent.co.uk